(PDF) P3.15-02 Carboplatin Dose Calculated Using Different

P3.15-02 Carboplatin Dose Calculated Using Different Formula for eGFR and Their Comparison With Actual Dose Administered in Lung Cancer Patients

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1878

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Dose-Finding and Sequencing Study of Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer

Cancer Research

Respiratory Medicine

English

P3.15-19 Risk Factors for Osteoporosis in Lung Cancer Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.13-15 First-Line Afatinib Dose Initiation and Adjustment in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Comparison of 3DCRT Dose Distribution in Radiotherapy for Lung Cancer Patient by Using AAA and PBC Algorithms

International Letters of Chemistry, Physics and Astronomy

English

Low-Dose CT for Lung Cancer Screening

The Lancet Oncology

English

P2.03-030 Cumulative Smoking Dose Affects the Clinical Outcomes of EGFR-Mutated Lung Adenocarcinoma Patients Treated With EGFR-TKIs

Journal of Thoracic Oncology

Respiratory Medicine

English

Evaluation of Chemoradiotherapy of Low Dose Carboplatin (CBDCA) for Head and Neck Cancer.

Practica Otologica

Otorhinolaryngology

English

Prognostic Significance of Lung Radiation Dose in Patients With Esophageal Cancer Treated With Neoadjuvant Chemoradiotherapy

Radiation Oncology

Nuclear Medicine

English

P3.15-21 Real-World Experience of First-Line Afatinib Treatment in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English